Octreotide for esophageal variceal bleeding observed.doc

 PAGE \* MERGEFORMAT 6 Octreotide for esophageal variceal bleeding observed [Abstract] Objective To observe the effect of octreotide on esophageal variceal hemorrhage. Methods 50 cases of esophageal variceal bleeding hospitalized patients (both confirmed by endoscopy) were randomly divided into two groups: A group (25 cases) treated with octreotide, B group (25 cases) treated with vasopressin were observed hemostasis. Results octreotide group 91.5% success rate of hemostasis, composed of pituitrin power of 62%. Conclusion Octreotide for esophageal variceal bleeding significantly better than the posterior pituitary factors. [Keywords:] octreotide; pituitrin; esophageal variceal bleeding Upper gastrointestinal bleeding is the most common complication of cirrhosis of the liver, especially after esophageal variceal bleeding is difficult to stop the bleeding, the recurrence rate and mortality rate is high, our hospital Octreotide for esophageal variceal bleeding better effect, these are as follows . 1 Materials and Methods 1.1 General information on 50 patients within 24 h before admission hematemesis and (or) black stools, according to clinical manifestation, laboratory examination, B-ultrasound and endoscopy diagnosed as liver cirrhosis and esophageal variceal bleeding. This group of patients, male 34, female 16, aged 27 to 69 years (mean 50.2 + -3.2) years and 32 cases of liver cirrhosis, alcoholic cirrhosis in 15 cases, the other 2 cases. liver function classification: Child-PughA 14 cases of grade, B grade 28 cases, C grade in 8 cases. were divided into A group (25 cases) and B group (25 patients) in both treatment groups, A group treated with octreotide, B group treated with pituitrin. two groups in gender, age, bleeding, bleeding before admission average number of causes of bleeding, liver function classification and severity of the disease, etc. There was no significant difference. 1.2 Treatment A: with octreotide (brand name: Sandostatin)